Agilent Technologies, Inc. (NYSE:A – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty analysts that are currently covering the stock, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation, fourteen have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $170.33.
A number of research firms have recently issued reports on A. Piper Sandler assumed coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective on the stock. Barclays upped their price target on Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a research note on Thursday, August 27th. TD Cowen raised their price objective on Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday, August 27th. Wall Street Zen downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Morgan Stanley upped their target price on Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th.
View Our Latest Stock Report on Agilent Technologies
Insider Activity at Agilent Technologies
Institutional Investors Weigh In On Agilent Technologies
Institutional investors and hedge funds have recently made changes to their positions in the business. Bank of Nova Scotia purchased a new stake in Agilent Technologies during the second quarter valued at about $58,539,000. Dudley & Shanley Inc. raised its stake in shares of Agilent Technologies by 25.9% during the second quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock worth $9,232,000 after acquiring an additional 14,300 shares in the last quarter. BIP Wealth LLC bought a new stake in shares of Agilent Technologies in the 2nd quarter worth approximately $834,000. Capricorn Fund Managers Ltd bought a new stake in shares of Agilent Technologies in the 1st quarter worth approximately $8,161,000. Finally, Sivia Capital Partners LLC purchased a new stake in shares of Agilent Technologies in the 2nd quarter valued at $1,818,000.
Agilent Technologies Stock Performance
NYSE:A opened at $167.83 on Friday. The company has a market capitalization of $47.32 billion, a PE ratio of 33.04, a P/E/G ratio of 2.54 and a beta of 1.21. The company has a 50 day simple moving average of $152.80 and a two-hundred day simple moving average of $133.41. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. Agilent Technologies has a fifty-two week low of $108.35 and a fifty-two week high of $177.05.
Agilent Technologies (NYSE:A – Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same period in the previous year, the business earned $1.37 EPS. The firm’s revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts anticipate that Agilent Technologies will post 6.2 earnings per share for the current year.
Agilent Technologies Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th will be paid a dividend of $0.2550 per share. The ex-dividend date is Tuesday, October 6th. This represents a $1.02 annualized dividend and a yield of 0.6%. Agilent Technologies’s dividend payout ratio (DPR) is 20.08%.
Agilent Technologies Company Profile
Agilent Technologies, Inc is an analytical measurement and laboratory technology company serving the life sciences, diagnostics, pharmaceutical, chemical, environmental, food, energy and academic research markets. Its solutions help laboratories analyze the composition, quality and performance of materials, biological samples and other substances.
The company’s products and services include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy equipment, laboratory automation tools, software, consumables and supplies.
Recommended Stories
- Five stocks we like better than Agilent Technologies
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
